1-8 of 8
Guenter K.H. Auerswald
Close
Sort by
Journal Articles

Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER,

Mariasanta Napolitano, MD, Alberto Dolce, PhD, Angelika Batorova, MD, PhD, Guenter K.H. Auerswald, MD, Jean-Francois Schved, Sergio Siragusa, MD, Jens Bjerre Knudsen, MD, PhD, Jorgen Ingerslev, Carmen Altisent, MD, Kaan Kavakli, MD, Umran Caliskan, Tahir S Shamsi, MD, Marie Bertrand, MD, Sophie Aronis, MD, Giovanni Di Minno, Arlette Ruiz-Sáez, MD, Ampaiwan Chuansumrit, Rosario Perez Garrido, MD, Kanjaksha Ghosh, Narges Mirbehbahani, MD, Mehran Karimi, MD, Guglielmo Mariani, MD
Journal: Blood
Blood (2011) 118 (21): 3368.
https://doi.org/10.1182/blood.V118.21.3368.3368
Published: 2011
Journal Articles

Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience

Mariasanta Napolitano, MD, Alberto Dolce, PhD, Jorgen Ingerslev, Muriel Giansily-Blaizot, MD, PhD, Matteo ND Di Minno, Guenter K.H. Auerswald, MD, Arlette Ruiz de Saez, Annarita Tagliaferri, Angelika Batorova, MD, PhD, Teresa Maria Caimi, MD, Ampaiwan Chuansumrit, Maria Fernanda Lopez Fernandez, MD, Marie-Anne Bertrand, MD, Elisabeth Verdy, MD, Ezio Zanon, MD, Lien Abecassis, MD, Sophie Aronis, Sergio Siragusa, MD, Assunta Orecchioni, MD, Guglielmo Mariani, MD
Journal: Blood
Blood (2011) 118 (21): 1262.
https://doi.org/10.1182/blood.V118.21.1262.1262
Published: 2011
Journal Articles

At Disease Presentation, Severity of the Bleeding Symptom Predicts the Following Bleeds in Patients with FVII Deficiency

Matteo ND Di Minno, Angelika Batorova, MD, PhD, Mariasanta Napolitano, MD, Alberto Dolce, PhD, Giovanni Di Minno, MD, Francesco Bernardi, PhD, Jean-Francois Schved, Jørgen Ingerslev, MD, Muriel Giansily-Blaizot, MD, PhD, Guenter K.H. Auerswald, Sr., MD, Guglielmo Mariani, MD
Journal: Blood
Blood (2011) 118 (21): 30.
https://doi.org/10.1182/blood.V118.21.30.30
Published: 2011
Journal Articles

New Early Prophylaxis Regimen That Avoids Immunological Danger Signals Can Reduce Factor Eight (FVIII) Inhibitor Development Independent From Product Type Used.

Guenter K.H. Auerswald, MD, Christoph Bidlingmaier, Werner Engl, Heidi Chehadeh, Birgit M Reipert, PhD, Karin Kurnik, MD
Journal: Blood
Blood (2009) 114 (22): 221.
https://doi.org/10.1182/blood.V114.22.221.221
Published: 2009
Journal Articles

Secondary Prophylaxis with rFVIIa Improves Quality of Life of Hemophilia Patients with Inhibitors and Frequent Bleeds.

Barbara A. Konkle, Liselotte S. Ebbesen, Guenter K.H. Auerswald, Ute Friedrich, Rolf C.R. Ljung, Harold R. Roberts, W. Keith Hoots
Journal: Blood
Blood (2006) 108 (11): 1028.
https://doi.org/10.1182/blood.V108.11.1028.1028
Published: 2006
Journal Articles

Analysis of Structural Changes of the Factor VIII Gene: Intron 1 and 22, in Costarrican Families with Severe Haemophilia A.

Lizbeth Salazar-Sanchez, PhD, Guillermo Jimenez-Cruz, MD, Pilar Chaverri, MD, Winnie Schroeder, PhD, Karin Wulff, PhD, Miriam Sandoval, Lic, Guenter K.H. Auerswald, MD, Falko H. Herrmann, PhD
Journal: Blood
Blood (2005) 106 (11): 4096.
https://doi.org/10.1182/blood.V106.11.4096.4096
Published: 2005
Journal Articles

Immune Tolerance Induction (ITI) in Hemophilia A and Inhibitors using VWF Containing Factor VIII Concentrates.

Wolfhart Kreuz, MD, Carmen Escuriola Ettingshausen, MD, Guenter K.H. Auerswald, MD, Hans Herrmann Brackmann, MD, Thomas Klingebiel, MD
Journal: Blood
Blood (2004) 104 (11): 3092.
https://doi.org/10.1182/blood.V104.11.3092.3092
Published: 2004
Journal Articles

Inhibitor Incidence in Previously Untreated Patients (PUP) with Hemophilia A and B - a 10-Year-Follow up of the Prospective Multicenter Study.

Wolfhart Kreuz, MD, Guenter K.H. Auerswald, MD, Ulrich Budde, MD, Harald Lenk, MD
Journal: Blood
Blood (2004) 104 (11): 3983.
https://doi.org/10.1182/blood.V104.11.3983.3983
Published: 2004